Advertisement

Positive for Malignancy: Papillary Thyroid Carcinoma and Its Variants

  • Rana S. HodaEmail author
  • Rema Rao
  • Theresa Scognamiglio
Chapter
  • 498 Downloads

Abstract

  • Approximately 5% (2–16%) of all thyroid fine needle aspiration (FNA) results are malignant.

  • PTC is the most common form of thyroid cancer, comprising 83% of all diagnosed thyroid cancers.

  • Diagnostic accuracy of cytology for PTC is high; when a diagnosis of PTC is rendered, 94–96% prove to be PTC on resection.

Keywords

Classic papillary thyroid carcinoma C-PTC Variants of PTC Medullary thyroid carcinoma Cystic PTC Follicular variant of PTC Tall cell variant of PTC NIFTP Columnar cell variant of PTC Cribriform-morular variant of PTC Warthin-like PTC, Oncocytic variant of PTC 

Suggested Reading

Classic PTC

  1. 1.
    Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology II. Acta Cytol. 2016;60:397–8.CrossRefGoogle Scholar
  2. 2.
    Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology; definitions, criteria, and explanatory notes. 2nd ed. Cham: Springer International Publishing AG; 2018a.CrossRefGoogle Scholar
  3. 3.
    Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27:1341–6.  https://doi.org/10.1089/thy.2017.0500.CrossRefPubMedGoogle Scholar
  4. 4.
    Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid: a comprehensive guide for practicing thyroid pathology. 3rd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2019.Google Scholar
  5. 5.
    Sahpaz A, Önal B, Yeşilyurt A, Han Ü, Delibaşı T. BRAF(V600E) mutation, RET/PTC1 and PAX8-PPAR gamma rearrangements in follicular epithelium derived thyroid lesions – institutional experience and literature review. Balkan Med J. 2015;32:156–66.  https://doi.org/10.5152/balkanmedj.2015.15101.CrossRefPubMedPubMedCentralGoogle Scholar

FVPTC

  1. 6.
    Chai YJ, Kim SJ, Kim SC, Koo do H, Min HS, Lee KE, et al. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography. Clin Endocrinol. 2014;81:432–9.  https://doi.org/10.1111/cen.12433. CrossRefGoogle Scholar
  2. 7.
    Hahn SY, Shin JH, Lim HK, Jung SL, Oh YL, Choi IH, et al. Preoperative differentiation between noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and non-NIFTP. Clin Endocrinol. 2017;86:444–50.  https://doi.org/10.1111/cen.13263.CrossRefGoogle Scholar
  3. 8.
    Hung YP, Barletta JA. A user’s guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Histopathology. 2018;72:53–69.  https://doi.org/10.1111/his.13363.CrossRefPubMedGoogle Scholar
  4. 9.
    Lin HS, Komisar A, Opher E, Blaugrund SM. Follicular variant of papillary carcinoma: the diagnostic limitations of preoperative fine-needle aspiration and intraoperative frozen section evaluation. Laryngoscope. 2000;110:1431–6.CrossRefGoogle Scholar
  5. 10.
    Manimaran D, Karthikeyan TM, Khan DM, Thulasi RR. Follicular variant of papillary thyroid carcinoma: cytological indicators of diagnostic value. J Clin Diagn Res. 2014;8:46–8.  https://doi.org/10.7860/JCDR/2014/7477.4103.CrossRefGoogle Scholar
  6. 11.
    Point du Jour K, Schmitt AC, Chen AY, Griffith CC. Application of strict criteria for noninvasive follicular thyroid neoplasm with papillary-like nuclear features and encapsulated follicular variant papillary thyroid carcinoma: a retrospective study of 50 tumors previously diagnosed as follicular variant PTC. Endocr Pathol. 2018;29:35–42.  https://doi.org/10.1007/s12022-018-9537-4.CrossRefPubMedGoogle Scholar
  7. 12.
    Tallini G, Tuttle RM, Ghossein RA. The history of the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab.2017;102:15–22.  https://doi.org/10.1111/his.13363.CrossRefPubMedGoogle Scholar
  8. 13.
    Trabzonlu L, Paksoy N. Cytomorphological analysis of thyroid nodules diagnosed as follicular variant of papillary thyroid carcinoma: a fine needle aspiration study of diagnostic clues in 42 cases and the impact of using Bethesda system in reporting—an institutional experience. Endocr Pathol. 2018;29:351–6.  https://doi.org/10.1007/s12022-018-9550-9.CrossRefPubMedGoogle Scholar
  9. 14.
    Wu HH, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262–6.CrossRefGoogle Scholar

NIFTP

  1. 15.
    Bizzarro T, Martini M, Capodimonti S, Straccia P, Lombardi CP, Pontecorvi A, et al. Young investigator challenge: the morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: some insights into their identification. Cancer Cytopathol. 2016;124:699–710.  https://doi.org/10.1002/cncy.21777.CrossRefPubMedGoogle Scholar
  2. 16.
    Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M, et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda system for reporting thyroid cytopathology. Cancer Cytopathol. 2016;124:181–7.  https://doi.org/10.1002/cncy.21631.CrossRefPubMedGoogle Scholar
  3. 17.
    Legesse T, Parker L, Heath J, Staats PN. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features. J Am Soc Cytopathol. 2019;8(1):11–7.  https://doi.org/10.1016/j.jasc.2018.07.004.CrossRefPubMedGoogle Scholar
  4. 18.
    Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023–9.  https://doi.org/10.1001/jamaoncol.2016.0386.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 19.
    Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, et al. Molecular testing of nodules with a suspicious or malignant cytologic diagnosis in the setting of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Endocr Pathol. 2018;29:68–74.  https://doi.org/10.1007/s12022-018-9515-x.CrossRefPubMedGoogle Scholar
  6. 20.
    Zhou H, Baloch ZW, Nayar R, Bizzarro T, Fadda G, Adhikari-Guragain D, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): implications for the risk of malignancy (ROM) in the Bethesda system for reporting thyroid cytopathology (TBSRTC). Cancer Cytopathol. 2018;126:20–6.  https://doi.org/10.1002/cncy.21926.CrossRefPubMedGoogle Scholar

TCV-PTC

  1. 21.
    Baum JE, Soong L, Scognamiglio T, Margolskee EM, Hoda RS, Rao R. Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid-based cytology. Diagn Cytopathol. 2019;47:541–6.  https://doi.org/10.1002/dc.24146.CrossRefPubMedGoogle Scholar
  2. 22.
    Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207–15.CrossRefGoogle Scholar
  3. 23.
    Kaw YT. Fine needle aspiration cytology of the tall cell variant of papillary carcinoma of the thyroid. Acta Cytol. 1994;38:282.PubMedGoogle Scholar
  4. 24.
    Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ, Kang CS. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2014;42:11–7.CrossRefGoogle Scholar

Cystic PTC

  1. 25.
    Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology; definitions, criteria, and explanatory notes. 2nd ed. Cham: Springer International Publishing AG; 2018b.CrossRefGoogle Scholar
  2. 26.
    Clark DP, Faquin WC. The thyroid cytopathology. 2nd ed. New York: Springer; 2010.CrossRefGoogle Scholar
  3. 27.
    Faquin WC, Cibas ES, Renshaw AA. “Atypical” cells in fine-needle aspiration biopsy specimens of benign thyroid cysts. Cancer. 2005;105:71–9.CrossRefGoogle Scholar
  4. 28.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.  https://doi.org/10.1089/thy.2015.0020.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 29.
    Hoda RS, VandenBussche C, Hoda SA. Diagnostic liquid-based cytology. New York: Springer; 2017.CrossRefGoogle Scholar
  6. 30.
    Li W, Zhu Q, Jiang Y, Zhang Q, Meng Z, Sun J, et al. Partially cystic thyroid nodules in ultrasound-guided fine needle aspiration: prevalence of thyroid carcinoma and ultrasound features. Medicine (Baltimore). 2017;96:e8689.  https://doi.org/10.1097/MD.0000000000008689.CrossRefGoogle Scholar
  7. 31.
    Mokhtari M, Kumar PV, Hayati K. Fine-needle aspiration study of cystic papillary thyroid carcinoma: rare cytological findings. J Cytol. 2016;33:120–4.CrossRefGoogle Scholar

OV-PTC

  1. 32.
    Carr AA, Yen TWF, Ortiz DI, Hunt BC, Fareau G, Massey BL, et al. Patients with oncocytic variant papillary thyroid carcinoma have a similar prognosis to matched classical papillary thyroid carcinoma controls. Thyroid. 2018;28:1462–7.  https://doi.org/10.1089/thy.2017.0603.CrossRefPubMedGoogle Scholar
  2. 33.
    Hong JH, Yi HS, Yi S, Kim HW, Lee J, Kim KS. Implications of oncocytic change in papillary thyroid cancer. Clin Endocrinol. 2016;85:797–804.  https://doi.org/10.1111/cen.13115.CrossRefGoogle Scholar
  3. 34.
    Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011;5:51–6.  https://doi.org/10.1007/s12105-010-0236-9.CrossRefPubMedPubMedCentralGoogle Scholar

WLV-PTC

  1. 35.
    Apel RL, Asa SL, LiVolsi VA. Papillary Hürthle cell carcinoma with lymphocytic stroma. “Warthin-like tumor” of the thyroid. Am J Surg Pathol. 1995;19(7):810–4.CrossRefGoogle Scholar
  2. 36.
    Chong Y, Suh S, Kim TJ, Lee EJ. Fine needle aspiration cytology of Warthin-like papillary thyroid carcinoma: a brief case report. Korean J Pathol. 2014;48:170–3.  https://doi.org/10.4132/KoreanJPathol.2014.48.2.170.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 37.
    Evranos B, Polat SB, Baser H, Ozdemir D, Kilicarslan A, Yalcin A, et al. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma. Cytopathology. 2017;28:259–67.  https://doi.org/10.1111/cyt.12384.CrossRefPubMedGoogle Scholar
  4. 38.
    Kim GR, Shin JH, Hahn SY, Ko EY, Oh YL. Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma. Endocr J. 2016;63:329–35.  https://doi.org/10.1507/endocrj.EJ15-0620.CrossRefPubMedGoogle Scholar
  5. 39.
    Kim J, Lim BJ, Hong SW, Pyo JY. Preoperative cytologic diagnosis of Warthin-like variant of papillary thyroid carcinoma. J Pathol Transl Med. 2018;52:105–9.  https://doi.org/10.4132/jptm.2017.12.26.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 40.
    Paker I, Kokenek TD, Yılmazer D, Seker GE, Alper M. Oncocytic variant of papillary thyroid carcinoma with lymphocytic stroma (Warthin-like variant): report of a case with fine needle aspiration cytology and review of the literature. Cytopathology. 2012;23:408–10.  https://doi.org/10.1111/j.1365-2303.2011.00877.x.CrossRefPubMedGoogle Scholar
  7. 41.
    Yousef O, Dichard A, Bocklage T. Aspiration cytology features of the Warthin tumor-like variant of papillary thyroid carcinoma. A report of two cases. Acta Cytol. 1997;41(4 Suppl):1361–8.CrossRefGoogle Scholar

CMV-PTC

  1. 42.
    Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, Sánchez-Ares M, Abdulkader I, Eloy C, et al. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway. Mod Pathol. 2018;31:1168–79.  https://doi.org/10.1038/s41379-018-0070-2.CrossRefPubMedGoogle Scholar
  2. 43.
    Hirokawa M, Maekawa M, Kuma S, Miyauchi A. Cribriform-morular variant of papillary thyroid carcinoma--cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol. 2010;38:890–6.  https://doi.org/10.1002/dc.21309.CrossRefPubMedGoogle Scholar

CCV-PTC

  1. 44.
    Bongiovanni M, Mermod M, Canberk S, Saglietti C, Sykiotis GP, Pusztaszeri M, et al. Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review. Cancer Cytopathol. 2017;125:389–97.  https://doi.org/10.1002/cncy.21860.CrossRefPubMedGoogle Scholar
  2. 45.
    Evans HL. Columnar cell carcinoma of the thyroid: a report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986;85:77–80.CrossRefGoogle Scholar
  3. 46.
    Tranchida P, Bernacki E, Budev H, Giorgadze T. Preoperative cytologic diagnosis of papillary thyroid carcinoma with mixed columnar cell and tall cell features. Diagn Cytopathol. 2012;40(Suppl 1):E4–7.  https://doi.org/10.1002/dc.21616.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.CBLPathRye BrookUSA
  2. 2.Department of Pathology and Laboratory MedicineNew York Presbyterian Hospital, Weill Cornell Medical CollegeNew YorkUSA

Personalised recommendations